Conclusions inconsistent with results with amphetamines and divalproex.
Kruszewski
Stefan P
SP
Paczynski
Richard
R
D000662:Amphetamines / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000453:epidemiology; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000453:epidemiology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D015897:Comorbidity; D018592:Cross-Over Studies; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design / Q000592:standards*; D018401:Sample Size; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use*
D000662:Amphetamines; D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D010919:Placebos; D014635:Valproic Acid